The federal jury that this week ordered Monsanto to pay $80 million for allegedly causing a man’s cancer likely was swayed by internal documents suggesting the unit of Bayer AG had improperly influenced regulators to keep its Roundup weedkiller from being classified a carcinogen.
Recent News About Monsanto Company View More
Jury finds Roundup was substantial factor in causing non-Hodgkin’s lymphoma; But Bayer stands by product heading into phase 2
After nearly a week of deliberation, a San Francisco federal jury found that the Monsanto product Roundup was a “substantial factor” in causing a Northern California man’s non-Hodgkin’s Lymphoma.
SAN FRANCISCO - As Monsanto appeals a closely-watched case over its leading weed-killer Roundup, and readies several more cases for trial in both federal and state courts, a looming question is whether the company’s conduct is truly worthy of large punitive damages, one legal expert says.